| 臺北醫學大學 |
2011 |
Orai1/CRACM1 Overexpression Suppresses Cell Proliferation via Attenuation of the Store-Operated Calcium Influx-mediated Signalling Pathway in A549 Lung Cancer Cells
|
MF, Hou;HC, Kuo;JH, Li;YS, Wang;CC, Chang;KC, Chen;WC, Chen;CC, Chiu;Yang, S;WC, Chang |
| 臺北醫學大學 |
2011 |
Orai1/CRACM1 Overexpression Suppresses Cell Proliferation via Attenuation of the Store-Operated Calcium Influx-mediated Signalling Pathway in A549 Lung Cancer Cells
|
Hou, MF;Kuo, HC;Li, JH;Wang, YS;Chang, CC;Chen, KC;Chen, WC;Chiu, CC;Yang, S;Chang, WC |
| 國立臺灣海洋大學 |
2008-03-15 |
Orai1–STIM1 formed store-operated Ca2+ channels (SOCs) as the molecular components needed for Pb2+ entry in living cells
|
Yu-Fen Chang;Hsiao-Chuan Teng;Sha-Yen Cheng;Chin-Tien Wang;Shi-Hwa Chiou;Lung-Sen Kao;Fu-Jen Kao;Arthur Chiou;De-Ming Yang |
| 高雄醫學大學 |
2012 |
ORAI1基因多型性與台灣族群中先天性甲狀腺功能低下之相關性研究
|
陳利旻;徐瑜彣;張偉嶠;蕭惠彬;陳百薰;趙美琴* |
| 國立臺灣大學 |
2012 |
Oral Absorbable Fat-soluble Vitamin Formulation in Pediatric Patients With Cholestasis
|
Shen, Yu-Mei; Wu, Jia-Feng; Hsu, Hong-Yuan; Ni, Yen-Hsuan; Chang, Mei-Hwei; Liu, Yu-Wen; Lai, Hong-Shiee; Hsu, Wen-Ming; Weng, Hui-Ling; Chen, Huey-Ling; 許文明; 倪衍玄; 張美惠; 許宏遠; 吳嘉峰; 賴鴻緒; 翁慧玲; 陳慧玲 |
| 國立臺灣大學 |
2012 |
Oral Absorbable Fat-soluble Vitamin Formulation in Pediatric Patients With Cholestasis
|
Shen, Yu-Mei; Wu, Jia-Feng; Hsu, Hong-Yuan; Ni, Yen-Hsuan; Chang, Mei-Hwei; Liu, Yu-Wen; Lai, Hong-Shiee; Hsu, Wen-Ming; Weng, Hui-Ling; Chen, Huey-Ling; 許文明; 倪衍玄; 張美惠; 許宏遠; 吳嘉峰; 賴鴻緒; 翁慧玲; 陳慧玲 |
| 臺大學術典藏 |
2019-12-25T04:04:15Z |
Oral absorbable fat-soluble vitamin formulation in pediatric patients with cholestasis
|
Shen Y.-M.; Wu J.-F.; HONG-YUAN HSU; Ni Y.-H.; Chang M.-H.; Liu Y.-W.; Lai H.-S.; Hsu W.-M.; Weng H.-L.; Chen H.-L. |
| 臺大學術典藏 |
2020-02-24T05:13:17Z |
Oral absorbable fat-soluble vitamin formulation in pediatric patients with cholestasis
|
Shen Y.-M.; Wu J.-F.; Hsu H.-Y.; Ni Y.-H.; Chang M.-H.; Liu Y.-W.; HONG-SHIEE LAI; Hsu W.-M.; Weng H.-L.; Chen H.-L. |
| 臺大學術典藏 |
2020-12-28T08:14:28Z |
Oral absorbable fat-soluble vitamin formulation in pediatric patients with cholestasis
|
Shen Y.-M.; Wu J.-F.; Hsu H.-Y.; YEN-HSUAN NI; Chang M.-H.; Liu Y.-W.; Lai H.-S.; Hsu W.-M.; Weng H.-L.; Chen H.-L. |
| 臺大學術典藏 |
2021-01-04T07:33:43Z |
Oral absorbable fat-soluble vitamin formulation in pediatric patients with cholestasis
|
Ni Y.-H.; Hsu H.-Y.; Shen Y.-M.; Wu J.-F.; Shen Y.-M.;Wu J.-F.;Hsu H.-Y.;Ni Y.-H.;Mei-Hwei Chang;Liu Y.-W.;Lai H.-S.;Hsu W.-M.;Weng H.-L.;Chen H.-L.; MEI-HWEI CHANG; Liu Y.-W.; Lai H.-S.; Hsu W.-M.; Weng H.-L.; Chen H.-L. |
